Ricky Bindra's Contact Details

Ricky Bindra's Company Details

New Liberty Proteomics Corp.

N/A, , US • 20 - 49 Employees
BioTech/Drugs

For the first time in the history of drug development, a single, biologically relevant family of assessments inform a drug candidate's profile. NLP's FALCON uniquely integrates four, interlocking applications: Drug Screening, MOA, Dx/CDx and Personalized/Precision Medicine. Data collected from Drug Screening is directly comparable to that for determination of MOA's, and the same is true for development of Dx/CDx and implementation of Personalized/Precision Medicine. Core methods, RAPTOR and RAVEN, assess fundamental biological events – protein interactions and protein degradation – in real time, in situ, and in media of any biological complexity. RAPTOR and RAVEN not only anticipate clinical outcomes, they are directly applicable in the trials themselves. Thus the need for improved clinical performance predictability is met, while the need for clinical utility is exceeded